Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Soleno Therapeutics (SLNO) Assets Average (2016 - 2026)

Soleno Therapeutics has reported Assets Average over the past 9 years, most recently at $581.9 million for Q4 2025.

  • Quarterly Assets Average rose 193.9% to $581.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $581.9 million through Dec 2025, up 193.9% year-over-year, with the annual reading at $447.4 million for FY2025, N/A changed from the prior year.
  • Assets Average was $581.9 million for Q4 2025 at Soleno Therapeutics, up from $466.1 million in the prior quarter.
  • Over five years, Assets Average peaked at $581.9 million in Q4 2025 and troughed at $198.0 million in Q4 2024.